VarCov Co’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-9,549
Closed -$250K – 360
2026
Q2
$250K Buy
+9,549
New +$222K 0.1% 308

Other funds holding ARQT

VarCov Co's ARQT Position: Q3 2026 in Review

VarCov Co sold out of Arcutis Biotherapeutics (ARQT) in Q3 2026, closing a stake of 9,549 shares — an estimated $250K sold.

VarCov Co first reported a position in ARQT in Q2 2026 and held it in 1 quarter. The position peaked at $250K in Q2 2026. 294 funds tracked by Wall St. Rank hold ARQT as of Q3 2026.

  • VarCov Co reported no remaining Arcutis Biotherapeutics position as of Q3 2026 after selling out during the quarter.
  • VarCov Co sold 9,549 Arcutis Biotherapeutics shares in Q3 2026, an estimated $250K.
  • VarCov Co first reported a position in Arcutis Biotherapeutics in Q2 2026 and held it in 1 quarter.
  • VarCov Co's Arcutis Biotherapeutics position peaked at $250K in Q2 2026.
  • 294 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q3 2026.

Based on VarCov Co's 13F filing for Q3 2026, filed 16 Nov 2026.